Australian-owned cancer treatment network Genesis Cancer Care (GenesisCare) has continued to build momentum following the challenges of the pandemic, booking revenue growth of 22% in the year ended 30 June 2023. The company, which has just emerged from Chapter 11 bankruptcy proceedings, said increased patient activity across all service lines contributed to revenue of £122.5m. It experienced high…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2024 All rights reserved LaingBuisson 
 has continued to build momentum following the challenges of the pandemic, booking revenue growth of 22% in the year ended 30 June 2023.){kind=link}